Ann-KathrinEisfeldMD

PubMed

• 93 citations
  Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
  Joshua J. Oaks, Ramasamy Santhanam, Christopher J. Walker, Steve R. Roof, Jason G. Harb
  Blood. 2013-09-12
• 15 citations
  High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
  Karilyn T Larkin, Deedra Nicolet, Benjamin J Kelly, Krzysztof Mrózek, Stephanie LaHaye
  Blood Advances. 2022-10-11
• 33 citations
  Dabrafenib Versus Dabrafenib + Trametinib in-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicen...
  Naifa L Busaidy, Bhavana Konda, Lai Wei, Lori J Wirth, Catherine Devine
  Thyroid. 2022-10-01

Abstracts/Posters

• DNA Methylation-Based Classification Highlights the Role of the JAK-STAT Pathway in Acute Myeloid Leukemia
  Ann-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)
  Ann-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity
  Ann-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Personalized Oncology in Acute Myeloid Leukemia (AML): Validation of the Prognostic Value of the Knowledge Bank Algorithm in Patients (Pts) Treated on Cancer and Leuke...
  Ann-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Next-Generation RNA Sequencing-Based Analysis Identifies a Novel Set of Prognostic Micrornas (miRs) in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
  Ann-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• The 2017 European Leukemianet Genetic Risk Classification Performs Poorly in Older Patients with Acute Myeloid Leukemia (AML) and Should be Refined to Identify Patient... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Mutations in Genes Associated with Familial Predisposition to Myeloid Neoplasms: Their Frequency and Associations with Pretreatment Characteristics in Adult Patients (... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical and Molecular Characteristics of Acute Myeloid Leukemia (AML) Patients with TP53 Mutations and TP73 Mutations 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Precision Medicine Heirarchical Classification Developed Using Variant Allele Frequency (VAF) for Treatment of Older Patients (Pts) with Acute Myeloid Leukemia (AML)... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Genome-Wide Association Study (GWAS) Identifies a Significant Acute Myeloid Leukemia (AML) Susceptibility Locus Near BICRA 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all